Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement

Journal of Endocrinological Investigation

Volumn 26, Issue 3, 2003, Pages 244-249

  Murdolo, Giuseppe ^a   Lucidi, P ^a   Di Loreto, C ^a   Parlanti, N ^a   De Cicco, A ^a   Fanelli, C ^a   Perriello, G ^a   Mughetti, D ^a   Pippi, R ^a   Brozzetti, A ^a   Santeusanio, F ^a   De Feo, P ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Ghrelin; rhGH therapy; Visceral obesity

Indexed keywords

C PEPTIDE; FATTY ACID; GHRELIN; GLUCOSE; GLYCEROL; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; LEPTIN; LIPID; PLACEBO; SOMATOMEDIN C;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIET RESTRICTION; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KINETICS; LIPID ANALYSIS; LIPOLYSIS; LOW DRUG DOSE; MALE; OBESITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SIDE EFFECT; STATISTICAL ANALYSIS;

EID: 12444305012     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345164     Document Type: Article

References (27)

1. Bouchard C. Etiology of overweight and obesity. In: Bouchard C. (Ed.), Physical Activity and Obesity. Human Kinetics Publishers, Champaign, IL, 2000, pp. 7-10.
2. Arvat E., Maccario M., Di Vito L. et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a non natural peptidyl GHS, and GH-relelasing hormone. J. Clin. Endocrinol. Metab. 2001, 86: 1169-1174.
3. Kojima M., Hosoda H., Date Y. et al. Ghrelin is a growth-hormone releasing acylated from the stomach. Nature 1999, 402: 656-660.
4. Nakazato M., Murakami N., Date Y. et al. A role of ghrelin in the central regulation of feeding. Nature 2001, 409: 194-198.
5. Tschöp M., Weyer C., Tataranni A. et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50: 707-709.
6. Shiiya T., Masamitsu N., Masanari M. et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 2002, 87: 240-244.
7. Maccario M., Grottoli S., Procopio M. et al. The GH/IGF-I axis in obeseity: Influence of neuroendocrine and metabolic factors. Int. J. Obes. Relat. Metab. Disord. 2000, Suppl. 2: 96-99.
8. De Boer H., Blok G.J., Van Der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 1995, 16: 63-86.
9. Johannsson G., Mårin P., Lönn L. et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism and reduces diastolic blood pressure. J. Clin. Endocrinol. Metab. 1997, 82: 727-734.
10. Lucidi P., Parlanti N., Piccioni F. et al. Short-term treatment with low doses of recombinant human GH stimulates lipolysis in visceral obese men. J. Clin. Endocrinol. Metab. 2002, 87: 3105-3109.
11. McGuire E., Helderman J., Tobin J., Andres R., Berman M. Effects of arterial venous sampling on analysis of glucose kinetics in man. J. Appl. Physiol. 1976, 41: 565-573.
12. Janssen J.A.M.J.L., Van Der Toorn FM., Hoffland L.J. et al. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur. J. Endocrinol. 2001, 145: 711-716.
13. Matthews D.R., Hosker J.P., Rudenski A.S. et al. Homeostasis model assessment: Insulin resistance and β-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-419.
14. Wolfe R.R. Glycerol flux. In: Wolfe R.R. (Ed.) Radioactive and Stable Isotope Tracers in Biomedicine. Wiley-Liss Inc, New York, 1992, p. 325.
15. Wolfe R.R. Appendix A: Lab methods. In: Wolfe R.R. (Ed.), Radioactive and Stable Isotope Tracers in Biomedicine. Wiley-Liss Inc, New York, 1992, pp. 427.
16. Horber F.F., Kahl J., Lecavalier L. et al. Determination of leucine and α-ketoisocaproic acid concentrations and specific activity in plasma and leucine specific activities in proteins using high-performance liquid chromatography. J. Chromatogr. 1989, 495: 81-94.
17. De Feo P., Gallai V., Mazzotta G, et al. Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. J. Clin. Invest. 1988, 82: 436-444.
18. Wright J.C., Bartke A. Ghrelin administration decreases insulin secretion in Ames dwarf mice. 83rd Annual Meeting of Endocrine Society, Denver, USA, 2001, (Abstract) p. 1, p. 98.
19. Van Der Toorn F.M., Janssen J.A.M.J.L., De Herder W.W., et al. Central ghrelin production does not substantially contribute to systemic ghrelin concentrations; A study in two subjects with active acromegaly. Europ. J. Endocrinol. 2002, 147: 195-199.
20. Hansen T.K., Dall L., Hosoda H. et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin. Endocrinol. (Oxf.) 2002, 56: 203-206.
21. Takaya K., Ariyasu H., Kanamoto N. et al. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab. 2000, 85: 4908-4911.
22. Tassone F., Broglio F., Gottero C, et al. Effetti metabolici ed ormonali della somministrazione acute di ghrelin in pazienti obesi. I Congresso Nazionale Società Italiana Obesità, Verona, Italy, 2002, pp. 78-98 (Abstract)
23. Cummings D.E., Purnell J.Q., Frayo R.S. et al. A preprandial rise in plasma ghrelin levels suggest a role in meal initiation in humans. Diabetes 2001, 50: 1714-1719.
24. Lucidi P., Murdolo G., Di Loreto C. et al. Ghrelin is not necessary for adequate hormonal counterregulation to insulin-induced hypoglycemia. Diabetes 2002, 51: 2911-2914.
25. Broglio F., Arvat E., Benso A. et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab. 2001, 86: 5083-5086.
26. Date Y., Kojima M., Hosoda H. et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell-type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141: 4255-4261.
27. Toshinai K., Mondal M.S., Nakazato M. et al. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem. Biophys. Res. Commun. 2001, 281: 1220-1225.